Search by Drug Name or NDC
NDC 65219-0335-82 Vitalipid N 1; 20; 15; 330 [iU]/mL; [iU]/mL; ug/mL; [iU]/mL Details
Vitalipid N 1; 20; 15; 330 [iU]/mL; [iU]/mL; ug/mL; [iU]/mL
Vitalipid N is a INTRAVENOUS EMULSION in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Fresenius Kabi USA, LLC. The primary component is .ALPHA.-TOCOPHEROL, DL-; ERGOCALCIFEROL; PHYTONADIONE; VITAMIN A PALMITATE.
Product Information
NDC | 65219-0335 |
---|---|
Product ID | 65219-335_804a9b58-4495-403f-9a45-8430a5f44dee |
Associated GPIs | |
GCN Sequence Number | 063895 |
GCN Sequence Number Description | fat emuls/vit A/vit D2/E/vit K AMPUL 990-5/10ML INTRAVEN |
HIC3 | C6Z |
HIC3 Description | MULTIVITAMIN PREPARATIONS |
GCN | 99607 |
HICL Sequence Number | 013336 |
HICL Sequence Number Description | FAT EMULSIONS/VITAMIN A PALMITATE/VITAMIN D2/VIT E/VIT K1 |
Brand/Generic | Brand |
Proprietary Name | Vitalipid N |
Proprietary Name Suffix | n/a |
Non-Proprietary Name | VITAMIN A PALMITATE, Ergocalciferol, .ALPHA.-TOCOPHEROL, DL-, PHYTONADIONE |
Product Type | HUMAN PRESCRIPTION DRUG |
Dosage Form | EMULSION |
Route | INTRAVENOUS |
Active Ingredient Strength | 1; 20; 15; 330 |
Active Ingredient Units | [iU]/mL; [iU]/mL; ug/mL; [iU]/mL |
Substance Name | .ALPHA.-TOCOPHEROL, DL-; ERGOCALCIFEROL; PHYTONADIONE; VITAMIN A PALMITATE |
Labeler Name | Fresenius Kabi USA, LLC |
Pharmaceutical Class | Ergocalciferols [CS], Increased Prothrombin Activity [PE], Provitamin D2 Compound [EPC], Reversed Anticoagulation Activity [PE], Vitamin A [CS], Vitamin A [EPC], Vitamin K [CS], Vitamin K [EPC], Warfarin Reversal Agent [EPC] |
DEA Schedule | n/a |
Marketing Category | UNAPPROVED DRUG FOR USE IN DRUG SHORTAGE |
Application Number | n/a |
Listing Certified Through | 2024-12-31 |
Package
NDC 65219-0335-82 (65219033582)
NDC Package Code | 65219-335-82 |
---|---|
Billing NDC | 65219033582 |
Package | 10 AMPULE in 1 CARTON (65219-335-82) / 10 mL in 1 AMPULE (65219-335-10) |
Marketing Start Date | 2023-08-18 |
NDC Exclude Flag | N |
Pricing Information | N/A |